KEGG   DRUG: Efavirenz, emtricitabine and tenofovir disoproxil
Entry
D10851            Mixture   Drug                                   
Name
Efavirenz, emtricitabine and tenofovir disoproxil;
Atripla (TN)
Product
ATRIPLA (Gilead Sciences)
  Generic
EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Aurobindo Pharma Limited), EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Camber Pharmaceuticals), EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Cipla USA), EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Laurus Labs Limited), EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Macleods Pharmaceuticals Limited), EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (REMEDYREPACK), EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Teva Pharmaceuticals USA)
Component
Efavirenz [DR:D00896], Emtricitabine [DR:D01199], Tenofovir disoproxil fumarate [DR:D01982]
Class
Antiviral
 DG03107  Anti-HIV agent
Remark
ATC code: J05AR06
Product: D10851<US>
Efficacy
Antiviral
  Disease
HIV-1 infection [DS:H01563]
Target
HIV-1 reverse transcriptase [KO:K24802]
  Pathway
ko03230  Viral genome structure
ko03240  Viral replication
ko03250  Viral life cycle - HIV-1
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J05 ANTIVIRALS FOR SYSTEMIC USE
   J05A DIRECT ACTING ANTIVIRALS
    J05AR Antivirals for treatment of HIV infections, combinations
     J05AR06 Emtricitabine, tenofovir disoproxil and efavirenz
      D10851  Efavirenz, emtricitabine and tenofovir disoproxil <US>
USP drug classification [BR:br08302]
 Antivirals
  Anti-HIV Combinations
   Efavirenz/ Emtricitabine/ Tenofovir Disoproxil Fumarate
    D10851  Efavirenz, emtricitabine and tenofovir disoproxil
Drug groups [BR:br08330]
 Antiviral
  DG03107  Anti-HIV agent
   D10851  Efavirenz, emtricitabine and tenofovir disoproxil
Drug classes [BR:br08332]
 Antiviral
  DG03107  Anti-HIV agent
   D10851  Efavirenz, emtricitabine and tenofovir disoproxil
Antimicrobials [BR:br08307]
 Antivirals
  Genome replication inhibitor
   HIV reverse transcriptase inhibitor
    D10851  Efavirenz, emtricitabine and tenofovir disoproxil <US>
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10851
Other DBs
CAS: 731772-50-2
PubChem: 319902651
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system